A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects

BACKGROUND: Atractylodes lancea (Thunb) DC. (AL) and bioactive compounds β-eudesmol and atractylodin have been demonstrated in the in vitro and in vivo studies for their potential clinical use in cholangiocarcinoma. The study was a randomized, double-blinded, placebo-controlled phase I clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulma, Inthuon, Panrit, Luxsana, Plengsuriyakarn, Tullayakorn, Chaijaroenkul, Wanna, Warathumpitak, Siriprapa, Na-Bangchang, Kesara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879636/
https://www.ncbi.nlm.nih.gov/pubmed/33579265
http://dx.doi.org/10.1186/s12906-020-03199-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879636/
https://www.ncbi.nlm.nih.gov/pubmed/33579265
http://dx.doi.org/10.1186/s12906-020-03199-6

Ejemplares similares